Table 1.
Biomarker | Type of Cell Death | Targeting Group | Imaging Modalities | Ref |
---|---|---|---|---|
Effector Caspases | Apoptosis | DEVD sequencea | BLI, Fluorescence | 30–48 |
Isatinsb | PET | 50, 51, 53,54 | ||
Acyloxymethyl ketonesb | Fluorescence | 56 | ||
Phosphatidylserine | Apoptosis, Necrosis | Annexin Vc,e | Fluorescence, PET, SPECT, MRI, Ultrasound | 74–78, 80,81 83, 85–90, 92–94, 96, 97 |
C2A domain of Synaptotagminc | Fluorescence, PET, SPECT, | 98–102 | ||
Lactadherinc | Fluorescence, SPECT | 103–105 | ||
LIKKPFa | MRI | 106–110 | ||
TLVSSLa | MRI | 108, 109 | ||
CLSYYPSY a | Fluorescence | 111 | ||
SVSVGMKPSPRPa | Fluorescence | 112 | ||
FNFRLKAGAKIRFGa | Fluorescence, SPECT | 113 | ||
cLac-2a | Fluorescence | 114 | ||
ZnDPAb | Fluorescence, SPECT, MRI | 115–124 | ||
Zn-cyclenb | Fluorescence, PET | 125 | ||
Phosphatidylethanolamine | Apoptosis, Necrosis | Duramycina | Fluorescence, SPECT | 127–129 |
Histones | Apoptosis | CQRPPR (Apopep-1)a | Fluorescence, PET | 137, 138, 207, 208 |
Mitochondrial Membrane Potential | Apoptosis | Phosphonium cationsb | PET | 64, 65 |
La Antigen | Late Apoptosis, Necrosis | La mAb 3B9d | Fluorescence, SPECT | 68, 69 |
APOMAB® DAB4d |
SPECT | 70 | ||
Heat Shock Proteins | Late Apoptosis, Necrosis | GSAO b | SPECT | 71 |
Autophagosome | Autophagy | LC3c | Fluorescence | 174–177 |
Exposed DNA | Necrosis | Hoechst-IRb | Fluorescence | 150 |
Gd-TOb | Fluorescence, MRI | 151, 152 | ||
Plasma Membrane Depolarization | Apoptosis | DDCb | Fluorescence | 139–141 |
ML-10b,e | Fluorescence, PET | 144–147 | ||
DFNSHb | Fluorescence, PET | 142, 143 | ||
Unknown | Necrosis | Hypericinb | Fluorescence, PET, SPECT, | 154–156, 158, 159 |
Pamoic Acidb | PET, SPECT | 160, 161 | ||
bis-DTPA-BI b | SPECT | 162 |
peptide
small molecule
protein
antibody
clinical studies